Home›Stocks›ACHV

ACHV — structural market context

Achieve Life Sciences, Inc. Co

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 16. Each line shows the earlier value, the later value and their dates.

Price

Close $6.38 (Oct 16) vs $6.97 (Oct 15): −8.46%.

Volume

1.40× its 20-session average (1.4M) on Oct 16.

Includes pre- and post-market trading.

Short interest

Short interest 17.5M shares (settlement Sep 30) vs 16.0M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 8 days with fails, largest 44K shares on Sep 23.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 5 days with fails, largest 40K shares on Sep 2.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

ACHV short interest & days to cover

SHARES SHORT
17.5M
% OF FLOAT
20.0%
DAYS TO COVER
10.9
CHANGE VS PRIOR
+9.3%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (17d ago)

ACHV fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 17d18K$7.69
2026-09-28 · 19d7K$7.54
2026-09-23 · 24d44K$8.12

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

ACHV insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 1 sale

InsiderTypeSharesValueFiled
Stewart Richard Alistair · directorSell (S)21K$175K2026-08-21

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

ACHV analyst ratings

FirmActionRatingPublished
Stifel Nicolausprice_target—2026-09-29

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is ACHV's short interest?
As of the FINRA settlement date 2026-09-30, ACHV had 17.5M shares sold short — 20.0% of its float, with 10.9 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying ACHV?
In the last 12 months of SEC Form 4 filings, ACHV recorded 0 insider purchases and 1 sale reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about ACHV?
The most recent action: Stifel Nicolaus price_target on 2026-09-29. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell ACHV?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with A

ACLLY · ACCELLERON INDS LTD ADR - UnspAMIGY · Admiral Group plc, Cardiff UnsAPA · APA CorporationAU · AngloGold Ashanti plcAVHNF · Ackermans & Van Haaren Sa OrdiAAPL · Apple Inc.All A →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.